alteminostat (CKD-581) / Chong Kun Dang  >>  Phase 1
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
alteminostat (CKD-581) / Chong Kun Dang
NCT01580371: Safety and Pharmacokinetic Profile of CKD-581

Completed
1
39
RoW
CKD-581, Histone Deacetylase Inhibitor
Chong Kun Dang Pharmaceutical
Lymphoma, Multiple Myeloma
03/16
06/16
NCT03150316: CKD-581 + Lenalidomide + Dexamethasone in Patients With Previously Treated Multiple Myeloma

Unknown status
1
18
RoW
Treat Regimen, CKD-581 lenalidomide dexamethasone regimen
Chong Kun Dang Pharmaceutical
Myeloma, Multiple
06/20
09/21
NCT03051841: CKD-581 + Bortezomib + Dexamethasone in Patients With Previously Treated Multiple Myeloma

Recruiting
1
18
RoW
CKD-581, CKD-581 bortezomib dexamethasone regimen
Chong Kun Dang Pharmaceutical
Myeloma, Multiple
04/21
11/22

Download Options